ContentsSEMAGLUTIDE 5mg Vials (for SC or IM Administration) X 2 . Ampoule: 2ml Sterile water for injection X2.
DescriptionGLYCOTIDE, an incretin mimetic like GLP-1, regulates blood sugar by boosting insulin release, lowering glucose, curbing appetite, and aiding weight loss. It mitigates stroke, heart attack, and mortality risks in type 2 diabetes with cardiovascular issues.
AdministrationIntramuscular or Subcutaneous injection.
StorageStore at room temperature away from heat and direct sunlight pre reconstitution.; Refrigerate between;2-8’C post Reconstitution.
DosageFor most patients, the recommended starting dosage of GLYCOTIDE is 0.25mg-.50mg once weekly, gradually increasing to 1.0mg per week. The dosing escalation helps patients acclimate to the medication and reduces the risk of gastrointestinal side effects. Close monitoring and individualized adjustment of dosage according to patient response is advised.
ContraindicationsGLYCOTIDE may cause some side effects. Common side effects include mild gastrointestinal discomfort such as nausea, vomiting, or diarrhea. These symptoms often subside as the body adjusts to the treatment. In rare cases, severe abdominal pain or signs of pancreatitis might occur; immediate medical attention is advised in such instances.
Special Precautions
  • Renal Impairment: Exercise caution in patients with renal impairment. SEMAGLUTIDE should be used with care in these individuals, and dosage adjustment might be necessary.
  • Gastrointestinal Effects: As with any GLP-1 receptor agonist, GLYCOTIDE may lead to gastrointestinal adverse effects, particularly during initial weeks of treatment. Patients should be informed about potential symptoms and advised on managing them.
  • Pancreatitis: Although rare, pancreatitis has been reported in patients using GLYCOTIDE. Monitor patients for persistent, severe abdominal pain and discontinue if pancreatitis is suspected.
Adverse Drug Reactions Rare adverse reactions may include hypersensitivity reactions, injection site reactions, and thyroid C-cell tumors. Patients should be monitored for signs of allergic reactions or any unusual symptoms and be educated about when to seek medical attention.
Drug InteractionsIt's essential to be cautious about potential drug interactions when prescribing GLYCOTIDE. It may interact with certain oral medications and insulin, necessitating dose adjustments. Always review a patient's current medication list before starting GLYCOTIDE and closely monitor for any adverse effects.
Disclaimer"Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice."